These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8328212)

  • 1. [Therapy of thrombosis with conventional heparin].
    Harenberg J
    Z Kardiol; 1993; 82 Suppl 2():71-5. PubMed ID: 8328212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity].
    Lopaciuk S; Meissner AJ; Ziemski JM; Tokarz A; Psuja P; Zawilska K; Głowiński S; Wołczyński Z; Czestochowska E; Tymiński W
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):704-7. PubMed ID: 1669137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous injections and intravenous infusion of sodium salt of heparin in the treatment of thrombosis of deep veins of the lower extremities].
    Lopaciuk S; Misiak A; Wisławski S; Ciesielski L; Korzycki J; Judkiewicz L; Lewandowski K; Tokarz A; Kłoczko J; Bielawiec M
    Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):949-52. PubMed ID: 2104438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
    Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H
    Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of heparin therapy: Controlled prospective trial.
    Salzman EW; Deykin D; Shapiro RM; Rosenberg R
    N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of venous thromboembolism.
    ten Cate JW; Koopman MM; Prins MH; Büller HR
    Thromb Haemost; 1995 Jul; 74(1):197-203. PubMed ID: 8578457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of deep vein thrombosis and pulmonary embolism.
    Turkstra F; Koopman MM; Büller HR
    Thromb Haemost; 1997 Jul; 78(1):489-96. PubMed ID: 9198202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and therapy of leg and pelvic deep vein thrombosis in pregnancy].
    Bahlmann F; Hofmann M; Meyer K; Schinzel H; Merz E; Trautmann K
    Zentralbl Gynakol; 2000; 122(7):374-82. PubMed ID: 10951708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulation in thrombolytic therapy: importance and future perspectives].
    Harenberg J; Heene DL
    Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of distal venous thrombosis of the lower extremity with "moderated" doses of heparin].
    Rosell Pradas J; Ruiz Morales M; Tovar Martínez JL; Vara Thorbeck R
    Angiologia; 1990; 42(3):100-4. PubMed ID: 2393158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
    Fagher B; Lundh B
    Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long term heparinotherapy and osteoporosis].
    Kher A; Toulemonde F; Raby C
    Nouv Presse Med; 1973 Jun; 2(23):1585-7. PubMed ID: 4713407
    [No Abstract]   [Full Text] [Related]  

  • 19. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.